AETHLON MEDICAL INC (AEMD) Stock Analyst Earnings Estimates
NASDAQ:AEMD - Nasdaq - US00808Y4061 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 660K 1.54% | 290K -56.06% | 570K 96.55% | -100.00% | |||
| EBITDA YoY % growth | -7.85M -33.05% | -10.3M -31.21% | -11.66M -13.20% | N/A -5.30% | N/A | N/A | |
| EBIT YoY % growth | -7.89M -33.05% | -10.42M -32.07% | -11.9M -14.20% | -13.661M -6.19% | -12.278M 2.84% | -12.501M -1.82% | |
| Operating Margin | -1,195.45% | -3,593.10% | -2,087.72% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A -125.02% | -4.49 36.81% | -5.90 -31.40% | -5.54 16.95% | -1.01 79.46% | -0.70 30.07% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.22 84.12% | -0.23 74.97% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -2.974M 16.64% | -3.075M -23.69% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.20 83.61% | -0.20 | 0.00 | -0.55% |
| Q1 2025 Q2Q % growth | -0.34 75.71% | -0.32 | -0.02 | -5.82% |
| Q4 2024 Q2Q % growth | -0.91 9.00% | -1.25 | 0.34 | 27.47% |
| Q3 2024 Q2Q % growth | -1.37 -14.17% | -1.25 | -0.12 | -9.20% |
| Q2 2024 Q2Q % growth | -1.22 32.22% | -1.43 | 0.21 | 14.57% |
| Q1 2024 Q2Q % growth | -1.40 26.32% | -1.33 | -0.07 | -5.58% |
| Q4 2023 Q2Q % growth | -1.00 61.54% | -1.33 | 0.33 | 24.59% |
| Q3 2023 Q2Q % growth | -1.20 25.00% | -0.82 | -0.38 | -47.06% |
| Q2 2023 Q2Q % growth | -1.80 -1,284.62% | -2.19 | 0.39 | 17.92% |
| Q1 2023 Q2Q % growth | -1.90 -1,087.50% | -2.24 | 0.34 | 15.33% |
| Q4 2022 Q2Q % growth | -2.60 -1,633.33% | -1.43 | -1.17 | -82.07% |
| Q3 2022 Q2Q % growth | -1.60 -700.00% | -1.33 | -0.27 | -20.66% |
| Q2 2022 Q2Q % growth | -0.13 13.33% | -0.15 | 0.02 | 15.03% |
| Q1 2022 Q2Q % growth | -0.16 | -0.13 | -0.03 | -20.66% |
| Q4 2021 Q2Q % growth | -0.15 31.19% | -0.20 | 0.05 | 25.23% |
| Q3 2021 Q2Q % growth | -0.20 33.33% | -0.17 | -0.03 | -18.84% |
| Q2 2021 Q2Q % growth | -0.15 88.37% | -0.12 | -0.03 | -22.55% |
| Q4 2020 Q2Q % growth | -0.22 83.85% | -0.16 | -0.05 | -33.58% |
| Q3 2020 Q2Q % growth | -0.30 81.82% | -1.05 | 0.75 | 71.44% |
| Q2 2020 Q2Q % growth | -1.29 -7.50% | -1.12 | -0.17 | -14.97% |
| Q1 2020 Q2Q % growth | -1.35 -50.00% | -1.22 | -0.13 | -10.29% |
| Q4 2019 Q2Q % growth | -1.35 | -1.07 | -0.28 | -26.05% |
| Q3 2019 Q2Q % growth | -1.65 | -1.07 | -0.58 | -54.06% |
| Q2 2019 Q2Q % growth | -1.20 | -1.07 | -0.13 | -12.04% |
| Q1 2019 Q2Q % growth | -0.90 | -1.22 | 0.32 | 26.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | 574.25K 5,642.50% | 574.25K | % | |
| Q3 2023 Q2Q % growth | -100.00% | 3.235M | -3.235M | -100.00% |
| Q2 2023 Q2Q % growth | -100.00% | 70.89K | -70.89K | -100.00% |
| Q1 2023 Q2Q % growth | -100.00% | 70.89K | -70.89K | -100.00% |
| Q4 2022 Q2Q % growth | 10K -66.67% | 735.42K | -725.42K | -98.64% |
| Q3 2022 Q2Q % growth | 20K -96.77% | 261.12K | -241.12K | -92.34% |
| Q2 2022 Q2Q % growth | 130K | 192.78K | -62.78K | -32.57% |
| Q1 2022 Q2Q % growth | 130K | 204K | -74K | -36.27% |
| Q4 2021 Q2Q % growth | 30K -85.71% | 380.797K | -350.797K | -92.12% |
| Q3 2021 Q2Q % growth | 620K 51.22% | 102K | 518K | 507.84% |
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | 210K 162.50% | 306K | -96K | -31.37% |
| Q3 2020 Q2Q % growth | 410K | 191.76K | 218.24K | 113.81% |
| Q2 2020 Q2Q % growth | 191.76K | -191.76K | -100.00% | |
| Q1 2020 Q2Q % growth | 30K -80.00% | 30K | % | |
| Q4 2019 Q2Q % growth | 80K | 51K | 29K | 56.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 80.95% | 0% | 3.27% |
| Revenue | N/A | N/A | N/A | N/A |